Firefly Neuroscience (NASDAQ:AIFF) Stock Price Down 3% – Should You Sell?

Firefly Neuroscience, Inc. (NASDAQ:AIFF) traded down 3% during trading on Friday . The company traded as low as $2.49 and last traded at $2.62. 21,768 shares changed hands during trading, a decline of 73% from the average session volume of 82,088 shares. The stock had previously closed at $2.70.

Firefly Neuroscience Price Performance

The stock has a 50-day simple moving average of $3.08.

Institutional Trading of Firefly Neuroscience

An institutional investor recently bought a new position in Firefly Neuroscience stock. Waldron Private Wealth LLC bought a new stake in Firefly Neuroscience, Inc. (NASDAQ:AIFF) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 12,000 shares of the company’s stock, valued at approximately $36,000. Waldron Private Wealth LLC owned approximately 1.79% of Firefly Neuroscience at the end of the most recent reporting period. 4.96% of the stock is owned by institutional investors and hedge funds.

About Firefly Neuroscience

Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.